Login
Subscribe
The Pet Health Industry Takes on Canine Cancer
The Pet Health Industry Takes on Canine Cancer
Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.
Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.
biobusiness, cancer, drug development
Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs
Claire Asher | Apr 1, 2019 | 9 min read
Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018 | 9 min read
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
Take Two of These
Bob Grant | Jun 22, 2011 | 6 min read
Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.